{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T10:47:40Z","timestamp":1775040460937,"version":"3.50.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,12,13]],"date-time":"2023-12-13T00:00:00Z","timestamp":1702425600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,12,13]],"date-time":"2023-12-13T00:00:00Z","timestamp":1702425600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Thrombosis J"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Congenital antithrombin deficiency is an autosomal dominant disease that results in deep venous thrombosis and pulmonary embolism, which is mainly caused by mutations in the antithrombin gene (<jats:italic>SERPINC1<\/jats:italic>). Since <jats:italic>SERPINC1<\/jats:italic> is highly susceptible to alterations, severe structural and functional changes that promote thrombosis may occur. Clinical presentations vary from different alterations. We report a pregnant case with novel mutation in <jats:italic>SERPINC1<\/jats:italic> presenting transient antithrombin deficiency and multiple venous thromboembolisms.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>We report a case of a 36-year-old pregnant patient who was diagnosed with congenital antithrombin deficiency for carrying a novel heterozygous mutation, NM_000488:exon5:c.T9 38\u00a0C:p. M313T in <jats:italic>SERPINC1<\/jats:italic> presenting transient antithrombin deficiency and multiple venous thromboembolisms. Thrombolytic with alteplase and anticoagulant therapies with low-molecular-weight heparin and warfarin were administrated. After confirming the genetic analysis and the termination of pregnancy, rivaroxaban was administrated, and the thrombosis reduced.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Our study enriched the mutation database of <jats:italic>SERPINC1<\/jats:italic> gene, provided some new theoretical basis for gene diagnosis and genetic counseling of patients with transient antithrombin deficiency. While it still needs for subsequent exploration of molecular pathogenesis.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12959-023-00571-7","type":"journal-article","created":{"date-parts":[[2023,12,13]],"date-time":"2023-12-13T14:02:31Z","timestamp":1702476151000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Multiple venous thromboembolisms in a pregnant patient carrying a novel mutation in SERPINC1 (p.M313T) that causes a transient antithrombin deficiency: a case report"],"prefix":"10.1186","volume":"21","author":[{"given":"Yuwen","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yinling","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoli","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jue","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bing","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanmei","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,12,13]]},"reference":[{"key":"571_CR1","doi-asserted-by":"crossref","unstructured":"Kalaitzopoulos DR, Panagopoulos A, Samant S, Ghalib N, Kadillari J, Daniilidis A, et al. Management of venous thromboembolism in pregnancy. Thromb Res. 2022;106\u201313. \/Q1\/10.407;211.","DOI":"10.1016\/j.thromres.2022.02.002"},{"issue":"5","key":"571_CR2","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1515\/jpm-2022-0008","volume":"50","author":"V Bitsadze","year":"2022","unstructured":"Bitsadze V, Khizroeva J, Alexander M, Elalamy I. Venous Thrombosis risk factors in pregnant women. J Perinat Med. 2022;50(5):505\u201318.","journal-title":"J Perinat Med"},{"key":"571_CR3","doi-asserted-by":"crossref","unstructured":"Blondon M, Martinez de Tejada B, Glauser F, Righini M, Robert-Ebadi H. Management of high-risk Pulmonary Embolism in pregnancy. Thromb Res. 2021;57\u201365. \/Q1\/10.407;204.","DOI":"10.1016\/j.thromres.2021.05.019"},{"key":"571_CR4","doi-asserted-by":"crossref","unstructured":"Zhang H, Hu Y, Pan D, Xv Y, Shen W. Genetic Analysis of a Pedigree With Antithrombin and Prothrombin Compound Mutations and Antithrombin Heterozygotes. Front Genet. 2022\/Q1\/4.772;13:832582.","DOI":"10.3389\/fgene.2022.832582"},{"issue":"11","key":"571_CR5","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1016\/j.biochi.2010.05.011","volume":"92","author":"ST Olson","year":"2010","unstructured":"Olson ST, Richard B, Izaguirre G, Schedin-Weiss S, Gettins PG. Molecular mechanisms of antithrombin-heparin regulation of blood clotting proteinases. A paradigm for understanding proteinase regulation by serpin family protein proteinase inhibitors. Biochimie. 2010;92(11):1587\u201396.","journal-title":"Biochimie"},{"key":"571_CR6","doi-asserted-by":"crossref","unstructured":"Wang HL, Ruan DD, Wu M, Ji YY, Hu XX, Wu QY et al. Identification and characterization of two SERPINC1 mutations causing congenital antithrombin deficiency. Thromb J 2023\/Q2\/5.509;21(1):3.","DOI":"10.1186\/s12959-022-00443-6"},{"key":"571_CR7","doi-asserted-by":"crossref","unstructured":"Yu H, Gai X, Wang J, Zhuang J, Guo W, Qiao R et al. Missense mutation of SERPINC1 (p.Ser426Leu) in a young patient presenting as refractory and recurrent venous thromboembolism: A case report. Front Cardiovasc Med. 2022\/Q2\/5.846;9:903785.","DOI":"10.3389\/fcvm.2022.903785"},{"key":"571_CR8","doi-asserted-by":"crossref","unstructured":"Morikawa M, Ieko M, Nakagawa-Akabane K, Umazume T, Chiba K, Kawaguchi S et al. Prevention of venous thromboembolism in pregnant women with congenital antithrombin deficiency: a retrospective study of a candidate protocol. Int J Hematol 2022\/Q4\/2.319;116(1):60\u201370.","DOI":"10.1007\/s12185-022-03327-7"},{"key":"571_CR9","doi-asserted-by":"crossref","unstructured":"Kovac M, Mitic G, Mikovic Z, Mandic V, Miljic P, Mitrovic M, et al. The influence of specific mutations in the AT gene (SERPINC1) on the type of pregnancy related Complications. Thromb Res. 2019;12\u20139. \/Q1\/10.407;173.","DOI":"10.1016\/j.thromres.2018.11.006"},{"key":"571_CR10","doi-asserted-by":"crossref","unstructured":"Nowak W, Treli\u0144ski J, Wypasek E, de la Morena-Barrio B, de la Morena-Barrio ME, Corral J. New SERPINC1 gene mutations in patients with antithrombin deficiency: antithrombin Lodz I, II, III, and IV. Pol Arch Intern Med. 2022\/Q2\/5.218;132(1).","DOI":"10.20452\/pamw.16158"},{"issue":"8615178","key":"571_CR11","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1111\/bjh.14658","volume":"Q1","author":"R Mulder","year":"2017","unstructured":"Mulder R, Croles FN, Mulder AB, Huntington JA, Meijer K, Lukens MV. SERPINC1 gene mutations in antithrombin deficiency. Br J Haematol. 2017;Q1(8615178):279\u201385.","journal-title":"Br J Haematol"},{"key":"571_CR12","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.thromres.2018.07.008","volume":"169","author":"J Corral","year":"2018","unstructured":"Corral J, de la Morena-Barrio ME, Vicente V. The genetics of antithrombin. Thromb Res. 2018;169:23\u20139.","journal-title":"Thromb Res"},{"key":"571_CR13","doi-asserted-by":"crossref","unstructured":"Tang LV, Tao Y, Feng Y, Ma J, Lin W, Zhang Y et al. Gene editing of human iPSCs rescues thrombophilia in hereditary antithrombin deficiency in mice. Sci Transl Med. 2022\/Q1\/19.319;14(673):eabq3202.","DOI":"10.1126\/scitranslmed.abq3202"},{"key":"571_CR14","doi-asserted-by":"crossref","unstructured":"Van Cott EM, Orlando C, Moore GW, Cooper PC, Meijer P, Marlar R. Recommendations for clinical laboratory testing for antithrombin deficiency; communication from the SSC of the ISTH. J Thromb Haemost. 2020;117\u201322. \/Q1\/10.7;18.","DOI":"10.1111\/jth.14648"},{"issue":"20310212","key":"571_CR15","doi-asserted-by":"publisher","first-page":"4028","DOI":"10.1182\/blood-2003-05-1560","volume":"Q1","author":"A Mushunje","year":"2003","unstructured":"Mushunje A, Zhou A, Carrell RW, Huntington JA. Heparin-induced substrate behavior of antithrombin Cambridge II. Blood. 2003;Q1(20310212):4028\u201334.","journal-title":"Blood"},{"key":"571_CR16","doi-asserted-by":"crossref","unstructured":"de la Morena-Barrio ME, Suchon P, Jacobsen EM, Iversen N, Mi\u00f1ano A, de la Morena-Barrio B et al. Two SERPINC1 variants affecting N-glycosylation of Asn224 cause severe thrombophilia not detected by functional assays. Blood 2022\/Q1\/20.3;140(2):140\u201351.","DOI":"10.1182\/blood.2021014708"},{"key":"571_CR17","doi-asserted-by":"crossref","unstructured":"Bravo-P\u00e9rez C, de la Morena-Barrio ME, de la Morena-Barrio B, Mi\u00f1ano A, Padilla J, Cifuentes R et al. Molecular and clinical characterization of transient antithrombin deficiency: A new concept in congenital thrombophilia. Am J Hematol. 2022\/Q1\/12.8;97(2):216\u2009\u2013\u200925.","DOI":"10.1002\/ajh.26413"},{"issue":"2","key":"571_CR18","first-page":"249","volume":"111","author":"B Luxembourg","year":"2014","unstructured":"Luxembourg B, Pavlova A, Geisen C, Spannagl M, Bergmann F, Krause M, et al. Impact of the type of SERPINC1 mutation and subtype of antithrombin deficiency on the thrombotic phenotype in hereditary antithrombin deficiency. Thromb Haemost. 2014;111(2):249\u201357.","journal-title":"Thromb Haemost"},{"key":"571_CR19","unstructured":"Corral J, Vicente V, Carrell RW. Thrombosis as a conformational disease. Haematologica. S3B\/2005\/Q1\/10.1;90(2):238\u2009\u2013\u200946."},{"key":"571_CR20","doi-asserted-by":"crossref","unstructured":"Picard V, Nowak-G\u00f6ttl U, Biron-Andreani C, Fouassier M, Frere C, Goualt-Heilman M et al. Molecular bases of antithrombin deficiency: twenty-two novel mutations in the antithrombin gene. Hum Mutat. S3B\/2006\/Q2\/3.9;27(6):600.","DOI":"10.1002\/humu.9425"},{"key":"571_CR21","doi-asserted-by":"crossref","unstructured":"Picard V, Nowak-G\u00f6ttl U, Biron-Andreani C, Fouassier M, Frere C, Goualt-Heilman M et al. Molecular bases of antithrombin deficiency: twenty-two novel mutations in the antithrombin gene. Hum Mutat. 2006\/Q2\/3.9;27(6):600.","DOI":"10.1002\/humu.9425"},{"key":"571_CR22","doi-asserted-by":"crossref","unstructured":"van Dam LF, Kroft LJM, van der Wal LI, Cannegieter SC, Eikenboom J, de Jonge E et al. Clinical and computed tomography characteristics of COVID-19 associated acute Pulmonary Embolism: a different phenotype of thrombotic Disease? Thromb Res. 2020\/Q1\/7.5;193:86\u2009\u2013\u20099.","DOI":"10.1016\/j.thromres.2020.06.010"},{"key":"571_CR23","doi-asserted-by":"crossref","unstructured":"Dolhnikoff M, Duarte-Neto AN, de Almeida Monteiro RA, da Silva LFF, de Oliveira EP, Saldiva PHN, et al. Pathological evidence of pulmonary thrombotic phenomena in severe COVID-19. J Thromb Haemost. 2020;61517\u20139. \/Q1\/10.4;18.","DOI":"10.1111\/jth.14844"},{"key":"571_CR24","doi-asserted-by":"crossref","unstructured":"Chan WS, Spencer FA, Ginsberg JS. Anatomic distribution of deep vein Thrombosis in pregnancy. Cmaj 2010\/Q1\/14.6;182(7):657\u201360.","DOI":"10.1503\/cmaj.091692"},{"key":"571_CR25","doi-asserted-by":"crossref","unstructured":"Hart C, Rott H, Heimerl S, Linnemann B. Management of Antithrombin Deficiency in pregnancy. Hamostaseologie 2022\/Q4\/2.145;42(5):320\u20139.","DOI":"10.1055\/a-1841-0399"}],"container-title":["Thrombosis Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12959-023-00571-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12959-023-00571-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12959-023-00571-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,13]],"date-time":"2023-12-13T14:06:45Z","timestamp":1702476405000},"score":1,"resource":{"primary":{"URL":"https:\/\/thrombosisjournal.biomedcentral.com\/articles\/10.1186\/s12959-023-00571-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,13]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["571"],"URL":"https:\/\/doi.org\/10.1186\/s12959-023-00571-7","relation":{},"ISSN":["1477-9560"],"issn-type":[{"value":"1477-9560","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,13]]},"assertion":[{"value":"29 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The inform of consent has been obtained from patient and patient\u2019s family.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"123"}}